MU Investments Co. Ltd. decreased its stake in UnitedHealth Group Inc (NYSE:UNH) by 12.2% in the fourth quarter, HoldingsChannel.com reports. The firm owned 25,150 shares of the healthcare conglomerate’s stock after selling 3,500 shares during the period. UnitedHealth Group comprises about 3.8% of MU Investments Co. Ltd.’s holdings, making the stock its 15th biggest position. MU Investments Co. Ltd.’s holdings in UnitedHealth Group were worth $5,603,000 at the end of the most recent reporting period.
Other institutional investors also recently made changes to their positions in the company. Blue Chip Partners Inc. purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $110,000. Bruderman Asset Management LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $114,000. Mitsubishi UFJ Securities Holdings Co. Ltd. boosted its holdings in shares of UnitedHealth Group by 433.3% in the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 640 shares of the healthcare conglomerate’s stock worth $119,000 after purchasing an additional 520 shares during the period. BDO Wealth Advisors LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter worth approximately $121,000. Finally, Acrospire Investment Management LLC boosted its holdings in shares of UnitedHealth Group by 130.7% in the 2nd quarter. Acrospire Investment Management LLC now owns 706 shares of the healthcare conglomerate’s stock worth $131,000 after purchasing an additional 400 shares during the period. Hedge funds and other institutional investors own 85.65% of the company’s stock.
A number of equities analysts have recently commented on the company. Zacks Investment Research upgraded UnitedHealth Group from a “hold” rating to a “buy” rating and set a $267.00 target price for the company in a report on Saturday, January 20th. Argus raised their price target on UnitedHealth Group to $270.00 and gave the stock a “buy” rating in a research note on Thursday, January 18th. Deutsche Bank raised their price target on UnitedHealth Group to $260.00 and gave the stock a “buy” rating in a research note on Wednesday, January 17th. Citigroup raised their price target on UnitedHealth Group from $235.00 to $268.00 and gave the stock a “buy” rating in a research note on Wednesday, January 17th. Finally, Piper Jaffray Companies reissued a “buy” rating and set a $259.00 price target on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Two research analysts have rated the stock with a hold rating and twenty-six have issued a buy rating to the company’s stock. UnitedHealth Group has an average rating of “Buy” and an average target price of $243.22.
UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, January 16th. The healthcare conglomerate reported $2.59 earnings per share for the quarter, beating the Zacks’ consensus estimate of $2.50 by $0.09. The business had revenue of $52.06 billion during the quarter, compared to analyst estimates of $51.57 billion. UnitedHealth Group had a return on equity of 21.29% and a net margin of 5.25%. UnitedHealth Group’s revenue was up 9.5% on a year-over-year basis. During the same period in the previous year, the company posted $2.11 EPS. equities research analysts predict that UnitedHealth Group Inc will post 12.51 earnings per share for the current year.
The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 20th. Shareholders of record on Friday, March 9th will be given a dividend of $0.75 per share. This represents a $3.00 dividend on an annualized basis and a yield of 1.31%. The ex-dividend date is Thursday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 31.58%.
In other UnitedHealth Group news, Director Michele J. Hooper sold 5,000 shares of UnitedHealth Group stock in a transaction on Monday, December 4th. The stock was sold at an average price of $222.20, for a total transaction of $1,111,000.00. Following the completion of the sale, the director now directly owns 36,989 shares of the company’s stock, valued at approximately $8,218,955.80. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Gail R. Wilensky sold 5,600 shares of UnitedHealth Group stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total value of $1,250,536.00. Following the sale, the director now directly owns 61,137 shares of the company’s stock, valued at $13,652,503.47. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 53,396 shares of company stock valued at $12,262,067. 0.89% of the stock is currently owned by corporate insiders.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Inc (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.